List of Excipients in API mirabegron
✉ Email this page to a colleague
Excipients in NDA-approved (novel) drugs containing mirabegron
Company | Tradename | Ingredient | NDC | Excipient | Potential Generic Entry |
---|---|---|---|---|---|
Astellas Pharma US Inc | MYRBETRIQ | mirabegron | 0469-2601 | BUTYLATED HYDROXYTOLUENE | |
Astellas Pharma US Inc | MYRBETRIQ | mirabegron | 0469-2601 | FERRIC OXIDE RED | |
Astellas Pharma US Inc | MYRBETRIQ | mirabegron | 0469-2601 | FERRIC OXIDE YELLOW | |
Astellas Pharma US Inc | MYRBETRIQ | mirabegron | 0469-2601 | HYDROXYPROPYL CELLULOSE | |
>Company | >Tradename | >Ingredient | >NDC | >Excipient | >Potential Generic Entry |
Excipients in ANDA-approved (generic) drugs containing mirabegron
Company | Ingredient | NDC | Excipient |
---|---|---|---|
Lupin Pharmaceuticals Inc | mirabegron | 68180-151 | BUTYLATED HYDROXYTOLUENE |
Lupin Pharmaceuticals Inc | mirabegron | 68180-151 | CELLULOSE, MICROCRYSTALLINE |
Lupin Pharmaceuticals Inc | mirabegron | 68180-151 | HYDROXYPROPYL CELLULOSE |
Lupin Pharmaceuticals Inc | mirabegron | 68180-151 | HYPROMELLOSE 2910 |
>Company | >Ingredient | >NDC | >Excipient |
Detailed excipient profiles for mirabegron
Excipient focus: BUTYLATED HYDROXYTOLUENE
mirabegron drug variants containing BUTYLATED HYDROXYTOLUENE
Company | Ingredient | NDC |
---|---|---|
Astellas Pharma US Inc | mirabegron | 0469-2601 |
Lupin Pharmaceuticals Inc | mirabegron | 68180-151 |
REMEDYREPACK INC | mirabegron | 70518-2435 |
REMEDYREPACK INC | mirabegron | 70518-3158 |
>Company | >Ingredient | >NDC |
mirabegron drug variants not containing BUTYLATED HYDROXYTOLUENE
Company | Ingredient | NDC |
---|---|---|
Zydus Pharmaceuticals (USA) Inc | mirabegron | 70710-1159 |
Cadila Healthcare Limited | mirabegron | 70771-1752 |
>Company | >Ingredient | >NDC |
Excipient focus: CELLULOSE, MICROCRYSTALLINE
mirabegron drug variants containing CELLULOSE, MICROCRYSTALLINE
Company | Ingredient | NDC |
---|---|---|
Lupin Pharmaceuticals Inc | mirabegron | 68180-151 |
>Company | >Ingredient | >NDC |
mirabegron drug variants not containing CELLULOSE, MICROCRYSTALLINE
Company | Ingredient | NDC |
---|---|---|
Astellas Pharma US Inc | mirabegron | 0469-2601 |
REMEDYREPACK INC | mirabegron | 70518-2435 |
REMEDYREPACK INC | mirabegron | 70518-3158 |
Zydus Pharmaceuticals (USA) Inc | mirabegron | 70710-1159 |
>Company | >Ingredient | >NDC |
Excipient focus: FERRIC OXIDE RED
mirabegron drug variants containing FERRIC OXIDE RED
Company | Ingredient | NDC |
---|---|---|
Astellas Pharma US Inc | mirabegron | 0469-2601 |
REMEDYREPACK INC | mirabegron | 70518-3158 |
Zydus Pharmaceuticals (USA) Inc | mirabegron | 70710-1159 |
Cadila Healthcare Limited | mirabegron | 70771-1752 |
>Company | >Ingredient | >NDC |
mirabegron drug variants not containing FERRIC OXIDE RED
Company | Ingredient | NDC |
---|---|---|
Lupin Pharmaceuticals Inc | mirabegron | 68180-151 |
REMEDYREPACK INC | mirabegron | 70518-2435 |
>Company | >Ingredient | >NDC |
Excipient focus: FERRIC OXIDE YELLOW
mirabegron drug variants containing FERRIC OXIDE YELLOW
Company | Ingredient | NDC |
---|---|---|
Astellas Pharma US Inc | mirabegron | 0469-2601 |
REMEDYREPACK INC | mirabegron | 70518-2435 |
REMEDYREPACK INC | mirabegron | 70518-3158 |
Zydus Pharmaceuticals (USA) Inc | mirabegron | 70710-1159 |
>Company | >Ingredient | >NDC |
mirabegron drug variants not containing FERRIC OXIDE YELLOW
Company | Ingredient | NDC |
---|---|---|
Lupin Pharmaceuticals Inc | mirabegron | 68180-151 |
>Company | >Ingredient | >NDC |
Excipient focus: FERROSOFERRIC OXIDE
mirabegron drug variants containing FERROSOFERRIC OXIDE
Company | Ingredient | NDC |
---|---|---|
Zydus Pharmaceuticals (USA) Inc | mirabegron | 70710-1159 |
Cadila Healthcare Limited | mirabegron | 70771-1752 |
>Company | >Ingredient | >NDC |
mirabegron drug variants not containing FERROSOFERRIC OXIDE
Company | Ingredient | NDC |
---|---|---|
Astellas Pharma US Inc | mirabegron | 0469-2601 |
Lupin Pharmaceuticals Inc | mirabegron | 68180-151 |
REMEDYREPACK INC | mirabegron | 70518-2435 |
REMEDYREPACK INC | mirabegron | 70518-3158 |
>Company | >Ingredient | >NDC |
Excipient focus: HYDROXYPROPYL CELLULOSE
mirabegron drug variants containing HYDROXYPROPYL CELLULOSE
Company | Ingredient | NDC |
---|---|---|
Astellas Pharma US Inc | mirabegron | 0469-2601 |
Lupin Pharmaceuticals Inc | mirabegron | 68180-151 |
REMEDYREPACK INC | mirabegron | 70518-2435 |
REMEDYREPACK INC | mirabegron | 70518-3158 |
>Company | >Ingredient | >NDC |
mirabegron drug variants not containing HYDROXYPROPYL CELLULOSE
Company | Ingredient | NDC |
---|---|---|
Zydus Pharmaceuticals (USA) Inc | mirabegron | 70710-1159 |
Cadila Healthcare Limited | mirabegron | 70771-1752 |
>Company | >Ingredient | >NDC |
Excipient focus: HYPROMELLOSE 2910
mirabegron drug variants containing HYPROMELLOSE 2910
Company | Ingredient | NDC |
---|---|---|
Astellas Pharma US Inc | mirabegron | 0469-2601 |
Lupin Pharmaceuticals Inc | mirabegron | 68180-151 |
REMEDYREPACK INC | mirabegron | 70518-2435 |
REMEDYREPACK INC | mirabegron | 70518-3158 |
>Company | >Ingredient | >NDC |
mirabegron drug variants not containing HYPROMELLOSE 2910
Company | Ingredient | NDC |
---|---|---|
>Company | >Ingredient | >NDC |
Excipient focus: MAGNESIUM STEARATE
mirabegron drug variants containing MAGNESIUM STEARATE
Company | Ingredient | NDC |
---|---|---|
Astellas Pharma US Inc | mirabegron | 0469-2601 |
Lupin Pharmaceuticals Inc | mirabegron | 68180-151 |
REMEDYREPACK INC | mirabegron | 70518-2435 |
REMEDYREPACK INC | mirabegron | 70518-3158 |
>Company | >Ingredient | >NDC |
mirabegron drug variants not containing MAGNESIUM STEARATE
Company | Ingredient | NDC |
---|---|---|
>Company | >Ingredient | >NDC |
Excipient focus: POLYETHYLENE GLYCOL 6000
mirabegron drug variants containing POLYETHYLENE GLYCOL 6000
Company | Ingredient | NDC |
---|---|---|
Lupin Pharmaceuticals Inc | mirabegron | 68180-151 |
Zydus Pharmaceuticals (USA) Inc | mirabegron | 70710-1159 |
Cadila Healthcare Limited | mirabegron | 70771-1752 |
>Company | >Ingredient | >NDC |
mirabegron drug variants not containing POLYETHYLENE GLYCOL 6000
Company | Ingredient | NDC |
---|---|---|
Astellas Pharma US Inc | mirabegron | 0469-2601 |
REMEDYREPACK INC | mirabegron | 70518-2435 |
REMEDYREPACK INC | mirabegron | 70518-3158 |
>Company | >Ingredient | >NDC |
Excipient focus: POLYETHYLENE GLYCOL 8000
mirabegron drug variants containing POLYETHYLENE GLYCOL 8000
Company | Ingredient | NDC |
---|---|---|
Astellas Pharma US Inc | mirabegron | 0469-2601 |
REMEDYREPACK INC | mirabegron | 70518-2435 |
REMEDYREPACK INC | mirabegron | 70518-3158 |
Zydus Pharmaceuticals (USA) Inc | mirabegron | 70710-1159 |
>Company | >Ingredient | >NDC |
mirabegron drug variants not containing POLYETHYLENE GLYCOL 8000
Company | Ingredient | NDC |
---|---|---|
Lupin Pharmaceuticals Inc | mirabegron | 68180-151 |
>Company | >Ingredient | >NDC |
Excipient focus: POLYETHYLENE OXIDE 1000000
mirabegron drug variants containing POLYETHYLENE OXIDE 1000000
Company | Ingredient | NDC |
---|---|---|
Lupin Pharmaceuticals Inc | mirabegron | 68180-151 |
>Company | >Ingredient | >NDC |
mirabegron drug variants not containing POLYETHYLENE OXIDE 1000000
Company | Ingredient | NDC |
---|---|---|
Astellas Pharma US Inc | mirabegron | 0469-2601 |
REMEDYREPACK INC | mirabegron | 70518-2435 |
REMEDYREPACK INC | mirabegron | 70518-3158 |
Zydus Pharmaceuticals (USA) Inc | mirabegron | 70710-1159 |
>Company | >Ingredient | >NDC |
Excipient focus: POLYETHYLENE OXIDE 200000
mirabegron drug variants containing POLYETHYLENE OXIDE 200000
Company | Ingredient | NDC |
---|---|---|
Zydus Pharmaceuticals (USA) Inc | mirabegron | 70710-1159 |
Cadila Healthcare Limited | mirabegron | 70771-1752 |
>Company | >Ingredient | >NDC |
mirabegron drug variants not containing POLYETHYLENE OXIDE 200000
Company | Ingredient | NDC |
---|---|---|
Astellas Pharma US Inc | mirabegron | 0469-2601 |
Lupin Pharmaceuticals Inc | mirabegron | 68180-151 |
REMEDYREPACK INC | mirabegron | 70518-2435 |
REMEDYREPACK INC | mirabegron | 70518-3158 |
>Company | >Ingredient | >NDC |
Excipient focus: POLYETHYLENE OXIDE 2000000
mirabegron drug variants containing POLYETHYLENE OXIDE 2000000
Company | Ingredient | NDC |
---|---|---|
Astellas Pharma US Inc | mirabegron | 0469-2601 |
REMEDYREPACK INC | mirabegron | 70518-2435 |
REMEDYREPACK INC | mirabegron | 70518-3158 |
Zydus Pharmaceuticals (USA) Inc | mirabegron | 70710-1159 |
>Company | >Ingredient | >NDC |
mirabegron drug variants not containing POLYETHYLENE OXIDE 2000000
Company | Ingredient | NDC |
---|---|---|
Lupin Pharmaceuticals Inc | mirabegron | 68180-151 |
>Company | >Ingredient | >NDC |
Excipient focus: TITANIUM DIOXIDE
mirabegron drug variants containing TITANIUM DIOXIDE
Company | Ingredient | NDC |
---|---|---|
Lupin Pharmaceuticals Inc | mirabegron | 68180-151 |
>Company | >Ingredient | >NDC |
mirabegron drug variants not containing TITANIUM DIOXIDE
Company | Ingredient | NDC |
---|---|---|
Astellas Pharma US Inc | mirabegron | 0469-2601 |
REMEDYREPACK INC | mirabegron | 70518-2435 |
REMEDYREPACK INC | mirabegron | 70518-3158 |
Zydus Pharmaceuticals (USA) Inc | mirabegron | 70710-1159 |
>Company | >Ingredient | >NDC |
Excipient focus: TRIACETIN
mirabegron drug variants containing TRIACETIN
Company | Ingredient | NDC |
---|---|---|
Lupin Pharmaceuticals Inc | mirabegron | 68180-151 |
>Company | >Ingredient | >NDC |
mirabegron drug variants not containing TRIACETIN
Company | Ingredient | NDC |
---|---|---|
Astellas Pharma US Inc | mirabegron | 0469-2601 |
REMEDYREPACK INC | mirabegron | 70518-2435 |
REMEDYREPACK INC | mirabegron | 70518-3158 |
Zydus Pharmaceuticals (USA) Inc | mirabegron | 70710-1159 |
>Company | >Ingredient | >NDC |
Make Better Decisions: Try a trial or see plans & pricing
Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.